SCHEMBL30360605

SCHEMBL30360605

CC(C)N1CCN(c2ccc(-c3cnc4cc(-c5cccc(S(=O)(=O)N(C)C)c5)n(C)c4c3)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ACVR1 Q04771 2/20 0.41
▸ FYN P06241 4/20 0.40
▸ MAP4K1 Q92918 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ PIK3CD O00329 2/20 0.35
▸ PIK3CA P42336 2/20 0.35
▸ PIK3CB P42338 2/20 0.35
▸ PIK3CG P48736 2/20 0.35
▸ PIK3R1 P27986 1/20 0.35
▸ SYK P43405 2/20 0.35
▸ JAK2 O60674 2/20 0.35
▸ MTOR P42345 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ TYK2 P29597 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ PTK2 Q05397 1/20 0.35
▸ GRIA2 P42262 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ PDE7A Q13946 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26516729 1.00 ACVR1 (0.41) ACVR1FYNMAP4K1HRH3PIK3CD
SCHEMBL26516639 0.90 ACVR1 (0.50) ACVR1FYNMAP4K1HRH3PIK3CD
SCHEMBL30360624 0.90 ACVR1 (0.50) ACVR1FYNMAP4K1HRH3PIK3CD
SCHEMBL26516741 0.87 ACVR1 (0.40) ACVR1FYNMAP4K1PIK3CBSYK
SCHEMBL30360622 0.87 ACVR1 (0.40) ACVR1FYNMAP4K1PIK3CBSYK
SCHEMBL26516557 0.83 MAP4K1 (0.47) ACVR1FYNMAP4K1HRH3PIK3CD
SCHEMBL30360601 0.83 MAP4K1 (0.47) ACVR1FYNMAP4K1HRH3PIK3CD
SCHEMBL26516919 0.79 FYN (0.43) ACVR1FYNMAP4K1HRH3SYK
SCHEMBL26516537 0.77 FYN (0.53) ACVR1FYNMAP4K1
SCHEMBL30360607 0.76 MAP4K1 (0.41) ACVR1FYNMAP4K1HRH3PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4200015-A1 SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 Bristol-Myers Squibb Company (US) 2023-06-28 — — EP claimed
CN-115956077-A Substituted heteroaryl compounds as TLR9 inhibitors 百时美施贵宝公司 2023-04-11 — — CN claimed
Send feedback